APYX compared with SOPH: revenue, margins and what each company keeps, and the suppliers and customers both name

APYXApyx Medical Corp

Mkt capRevenueRevenue

SOPHSOPHiA GENETICS SA

Mkt capRevenueRevenue

Compare

APYXApyx Medical Corp

SOPHSOPHiA GENETICS SA

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

APYX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±23.0%▼−2.64%×0.11

SOPH1 of 4 reports

Reportimpliedrealized× implied

Aug 4 '26—▲+20.21%—

= impliedAPYX realized, solidSOPH realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

APYXApyx Medical Corp

2.55· pre 2.55· delayed

Mkt cap$109.5MRevenue$14MQ2 FY26Revenue$53MFY25

SOPHSOPHiA GENETICS SA

7.62· pre 7.62· delayed

Pre-marketOct 30 '26delayed

Mkt cap$522.6MRevenue—Revenue—

Compare

Pre-marketOct 30 '26delayed

APYXApyx Medical Corp

SOPHSOPHiA GENETICS SA

2.55pre 2.55delayed

Price

7.62pre 7.62delayed

$109.5M

Mkt cap

$522.6M

Q2 FY26$14M

Revenue

—

FY25$53M

Revenue

—

APYX2.55vsSOPH7.62Pre-marketOct 30 '26delayed